Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University College of Medicine
Philadelphia, Pennsylvania
The increasing role of the cancer patient in medical decision making is one of the most important developments characterizing the current relationship between oncologists and their patients. It even has been noted that the oncology leadership of the FDA is increasingly assessing the patient perspective on toxicities of novel antineoplastic agents, and not simply